Thyrocare Technologies Limited
The Indian health-tech market is expected to grow at a CAGR of 39% and touch US$ 50 billion by 2033.
Thyrocare Technologies Limited is an India-based healthcare service provider. The company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests and regional processing laboratory in metro cities of India and other parts of Asia. The company offers technologies like Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The company offers cancer diagnosis and water testing through its brands, Nueclear and Whaters, respectively. The company tests cover varied age groups from offerings for prenatal screening to screening for hormonal imbalance, nutritional deficiencies and tracking lifestyle disorders.
- 2,115 employees
- 2,000 cities/towns
- Standalone total income of Rs. 522.15 crore (US$ 63 million) till the third quarter of FY23.
- India's first fully automated diagnostic laboratory
Thyrocare Technologies Limited: Think Thyroid Think Thyrocare
| Year | Milestone |
|---|---|
| 2023 |
In April 2023, Thyrocare has announced the launch of JAANCH, a brand that offers specialised health packages under one roof. Jaanch provides targeted, detailed, and affordable healthcare solutions to all Indians. The brand Jaanch consists of 26 packages under 9 vital specialties that cover heart health, diabetes, thyroid, cancer, sexually transmitted diseases (STDs), women’s reproductive health, skin care, hair fall and fever. |
| 2022 |
In March 2022, Thyrocare Technologies announced plans to launch four regional processing labs in the fourth quarter of FY22 in Nagpur, Ranchi, Raipur and Ahmedabad, in addition to two more regional processing labs in Jaipur and Visakhapatnam (Vizag) in March 2022. |
| 2021 |
In June 2021, online pharmacy startup PharmEasy acquired a majority stake of 66.1% in diagnostics chain Thyrocare Technologies for Rs. 4,546 crore (US$ 595.77 million). |
| 2018 |
Patna Regional Processing Laboratory (RRL) was launched. |
| 2017 |
Awarded The VCCircle healthcare company of the year. |
| 2016 |
Entered the Public listed sphere of healthcare - IPO |
| 2015 |
The company opened Regional Processing Laboratories (RPLs) in Delhi, Coimbatore, Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily. |
| 2014 |
The company had installed, India’s first and the world’s longest track automation system for seamless sample movements from Siemens Limited. |
| 2010 |
The company launched wellness packages under the brand name "Aarogyam". |
| 2007 |
The company receives accreditation from the College of American Pathologists (CAP). |
| 2005 |
The company received National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation. |
| 2000 |
The company was incorporated in the name and style of "Thyrocare Technologies Limited’ and received a certificate for commencement of operations. |
Partners
